DK138743C - - Google Patents

Info

Publication number
DK138743C
DK138743C DK130475A DK130475A DK138743C DK 138743 C DK138743 C DK 138743C DK 130475 A DK130475 A DK 130475A DK 130475 A DK130475 A DK 130475A DK 138743 C DK138743 C DK 138743C
Authority
DK
Denmark
Application number
DK130475A
Other languages
Danish (da)
Other versions
DK130475A (zh
DK138743B (da
Inventor
S B Kadin
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of DK130475A publication Critical patent/DK130475A/da
Publication of DK138743B publication Critical patent/DK138743B/da
Application granted granted Critical
Publication of DK138743C publication Critical patent/DK138743C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK130475AA 1974-04-01 1975-03-26 Analogifremgangsmåde til fremstilling af 1-oxo-1H-pyrimido (1,2-a)quinolin-2-carboxylsyre-forbindelser. DK138743B (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45679774A 1974-04-01 1974-04-01
US54722775A 1975-02-05 1975-02-05
US55496675A 1975-03-03 1975-03-03

Publications (3)

Publication Number Publication Date
DK130475A DK130475A (zh) 1975-10-02
DK138743B DK138743B (da) 1978-10-23
DK138743C true DK138743C (zh) 1979-04-02

Family

ID=27412681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK130475AA DK138743B (da) 1974-04-01 1975-03-26 Analogifremgangsmåde til fremstilling af 1-oxo-1H-pyrimido (1,2-a)quinolin-2-carboxylsyre-forbindelser.

Country Status (14)

Country Link
JP (1) JPS5427360B2 (zh)
CA (1) CA1033731A (zh)
DD (1) DD119425A5 (zh)
DE (1) DE2513930A1 (zh)
DK (1) DK138743B (zh)
ES (1) ES436155A1 (zh)
FI (1) FI750891A (zh)
FR (1) FR2265389B1 (zh)
GB (1) GB1451423A (zh)
IE (1) IE40893B1 (zh)
IL (1) IL46864A0 (zh)
LU (1) LU72184A1 (zh)
NL (1) NL7503692A (zh)
PH (1) PH10464A (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075343A (en) * 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
US4472401A (en) * 1981-11-27 1984-09-18 Roussel Uclaf Pyrimido-quinoxalines having antiallergic properties
US4510143A (en) * 1982-02-17 1985-04-09 Roussel Uclaf Antiallergic pyrimido[1,2-a]quinoxalin-2-carboxylic acid derivatives
WO1997037999A1 (en) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
US6989392B2 (en) 2002-06-18 2006-01-24 Abbott Laboratories 2-Aminoquinolines as melanin concentrating hormone receptor antagonists

Also Published As

Publication number Publication date
IE40893L (en) 1975-10-01
AU7937775A (en) 1976-09-23
GB1451423A (en) 1976-10-06
IL46864A0 (en) 1975-05-22
JPS50140499A (zh) 1975-11-11
ES436155A1 (es) 1977-02-01
FI750891A (zh) 1975-10-02
DK130475A (zh) 1975-10-02
DK138743B (da) 1978-10-23
DD119425A5 (zh) 1976-04-20
PH10464A (en) 1977-04-25
FR2265389A1 (zh) 1975-10-24
NL7503692A (nl) 1975-10-03
JPS5427360B2 (zh) 1979-09-10
IE40893B1 (en) 1979-09-12
DE2513930A1 (de) 1975-10-02
LU72184A1 (zh) 1976-03-02
CA1033731A (en) 1978-06-27
FR2265389B1 (zh) 1978-07-28

Similar Documents

Publication Publication Date Title
FR2295055B1 (zh)
FR2286010B1 (zh)
FR2264173B1 (zh)
FR2257845B1 (zh)
FR2277944B1 (zh)
FI751417A (zh)
FR2272989B1 (zh)
JPS5411223Y2 (zh)
FR2260921B1 (zh)
DK95574A (zh)
CH17274A4 (zh)
BG22709A1 (zh)
CH609150A5 (zh)
CH569666A5 (zh)
CH569220A5 (zh)
CH568539A5 (zh)
CH568134A5 (zh)
CH566915A5 (zh)
CH566410A5 (zh)
CH564833A5 (zh)
CH563933A5 (zh)
CH562521A5 (zh)
CH562462A5 (zh)
CH41675A4 (zh)
BG19987A1 (zh)

Legal Events

Date Code Title Description
PBP Patent lapsed
PUP Patent expired